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ABSTRACT
The type 3 iodothyronine deiodinase (D3) is a selenoenzyme that
inactivates thyroid hormones by removing a iodine from the
5-position of the tyrosyl ring. D3 is highly expressed in many
tissues during the early stages of development, and its activity is
regulated by selected growth factors and various hormones. To gain
further insights into the structure, functional role, and regulation
of this enzyme, we screened a mouse liver genomic library with a
rat D3 complementary DNA probe and isolated a 12-kb clone coding
for the Dio3. Restriction analysis followed by Southern blotting and
nucleotide sequencing demonstrated that the Dio3 contains a sin-
gle exon, 1853 bp in length, that encodes the entire length of the
messenger RNA expressed in murine placenta and neonatal skin.
Primer extension experiments identified two potential transcrip-
tional start sites located 77 and 60 nt upstream of the ATG trans-
lational start codon. The region immediately 59 to the start sites
contains consensus TATA, CAAT, and GC elements. Furthermore,
a 526-nucleotide genomic fragment from this region was demon-
strated to efficiently drive a luciferase reporter construct when
transfected into COS-7, XTC-2, or XL-2 cells or into primary cul-
tures of rat preadipocytes derived from neonatal brown fat. In
conclusion, D3 transcripts in the placenta and skin are encoded by
the Dio3 gene from a single exon whose expression is regulated by
an upstream region that contains several consensus promoter el-
ements. Further characterization of this gene will provide new
insights into the factors regulating the unique pattern of D3 ex-
pression during development. (Endocrinology 140: 124 –130, 1999)
THE TYPES 1, 2, and 3 iodothyronine deiodinases (D1,D2, and D3, respectively) constitute a group of en-
zymes that metabolize thyroid hormones and thus regulate
their levels in many tissues (1). Complementary DNAs from
several species that code for the three deiodinase isoforms
have been isolated (2–9), and all contain a TGA codon within
the open reading frame that is translated as selenocysteine.
The incorporation of this uncommon amino acid into the
protein is directed by a specific, conserved sequence in the
39-untranslated (39-UT) region of the messenger RNA
(mRNA) that is termed a selenocysteine insertion sequence
(SECIS) (10). Such cis-acting elements are a common feature
of all selenoprotein mRNAs described to date. Site-directed
mutagenesis has demonstrated that the selenocysteine resi-
due is located at the active site of these enzymes and is
essential for efficient catalysis (3, 5, 8). Recently, genomic
mouse and human DNA fragments containing the D1 gene
have been isolated and characterized, and the human gene
has been localized to chromosome 1p32-p33 (11, 12).
In contrast to D1 and D2, which catalyze primarily the
conversion of T4 to the more active hormone T3 by 59-deio-
dination, the D3 inactivates T4 and T3 by removing an iodine
from the 5-position or from the chemically equivalent
3-position on the inner ring (13). D3 is highly expressed
during development in many tissues, including placenta,
liver, intestine, skin, and central nervous system, whereas in
adult mammals expression appears to be restricted primarily
to the skin and brain (1). Mammalian D3 complementary
DNAs (cDNAs) of approximately 2.1 kb have been isolated
from rat neonatal skin (6) and human placenta libraries (7).
This size corresponds closely to that of the mRNA species in
these tissues that hybridize to the D3 cDNAs. In rat brain,
however, larger D3 transcripts of 3.6 and 3.3 kb have been
observed (6). cDNAs corresponding to these mRNAs have
not yet been identified.
Multiple hormonal and other regulatory factors have been
demonstrated to influence D3 expression. Thus, selected
growth factors (such as epidermal growth factor and acidic
and basic fibroblast growth factors) and phorbol esters mark-
edly induce D3 mRNA expression and activity in certain
undifferentiated cultured cells, such as preadipocytes from
brown fat and neonatal astroglial cells (14, 15). In addition,
T3 and retinoic acid stimulate D3 expression in these cells and
in vivo (16–18). These interesting patterns of expression and
regulation of D3 during development suggest an important
role for this enzyme in limiting the exposure of fetal tissues
to maternal thyroid hormones. Such a role would be of con-
siderable importance given the observed detrimental effects
during development of exposure to excessive levels of thy-
roid hormone (19, 20).
To further characterize the structural and functional fea-
tures of D3, we have isolated a mouse genomic DNA clone
that contains the gene (Dio3) for this enzyme. We report
herein the initial characterization of Dio3, including its pro-
moter region.
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Materials and Methods
Isolation of Dio3 clones
A murine (129/SvJ strain) genomic library constructed in the l Dash
II vector (Stratagene, La Jolla, CA) was screened by plaque hybridization
using the rat NS27-1 D3 cDNA (6) labeled with [32P]deoxy-CTP (ICN
Biochemicals, Inc., Costa Mesa, CA) as a probe. Radiolabeling of cDNA
probes for library screening and for Southern and Northern blotting
was performed using the oligolabeling kit from Pharmacia Biotech
(Piscataway, NJ), and the probe was purified through NucTrap columns
(Stratagene).
Restriction mapping, subcloning, and sequencing
Restriction mapping was performed by digestion of the Dio3 clone
with various restriction enzymes followed by Southern blotting using
standard procedures and part or all of the full-length rat NS43-1 D3
cDNA as a probe. Genomic fragments were subcloned into the following
vectors: pBluescript SK (Stratagene), pGL3 (Promega Corp., Madison,
WI), and pXP2 (21).
Sequencing was performed using vector- and gene-specific primers
and an automated sequencing system with fluorescent dye terminators
(PE Applied Biosystems, Foster City, CA).
Cell culture and transient transfections
COS-7 cells were obtained from American Type Culture Collection
(Manassas, VA) and cultured as previously described (9). The XTC-2 and
XL-2 cell lines, derived from Xenopus laevis adult carcass and premeta-
morphic tadpoles, respectively, were provided by Dr. J. Tata (National
Institute for Medical Research, The Ridgeway, London, UK) and cul-
tured in 0.6 3 L-15 (Leibovitz) medium (Sigma Chemical Co., St. Louis,
MO) supplemented with 10% FBS (Life Technologies, Gaithersburg,
MD). Primary cultures of rat preadipocytes were obtained as previously
described (16) from 18-day-old Sprague-Dawley rats, seeded at approx-
imately 600 cells/cm2, and cultured in high glucose DMEM supple-
mented with 10% FBS, 15 mm ascorbic acid, and gentamicin (50 mg/ml).
XTC-2 and XL-2 cell lines were plated at 3 3 105 cells/60-mm culture
dish the day before transfection, whereas primary brown fat preadipo-
cytes were plated at 1.5 3 104 cells/60-mm dish 4 days before trans-
fection. All cell types were transfected with 9 mg DNA using the calcium
phosphate method using a kit from Clontech (Palo Alto, CA). Cells were
cotransfected with 5 mg b-galactosidase expression vector (pCH110,
Pharmacia Biotech) to correct for transfection efficiency. After overnight
exposure to the DNA precipitate, the cells were cultured for 48 h before
harvesting. Luciferase and b-galactosidase activities were determined in
cell lysates using assay kits from Promega Corp. Light emission was
quantified using an EG & G Berthold microplate luminometer LB 96V
(Wallac, Gaitherburg, MD).
Northern blotting
RNA was prepared, and Northern blotting was performed as pre-
viously described (14). In brief, total RNA was obtained from rat brown
fat preadipocytes and from mouse placentas and fetal livers (17 days of
embryonic life) by a guanidinium chloride-based method. Polyadenyl-
ated [poly(A)1] RNA was prepared by standard oligo(deoxythymidine)-
cellulose affinity chromatography. RNA samples were run in a dena-
turing 1% agarose gel and blotted to a nylon membrane (Schleicher &
Schuell, Inc., Keene, NH). The filter was hybridized for 24 h at 42 C with
a radiolabeled restriction fragment from the mouse D3 genomic clone
(XhoI/BamHI) that included the coding region and the 59-UT region of
the Dio3. The filter was then washed twice for 30 min each time at 60 C
with 0.1% SDS and 0.1 3 SSC and autoradiographed.
Primer extension
Primer extension was performed according to the procedures of
Sambrook et al. (22) using an antisense primer (mST75) that spans the
translational start site (59-CAG AGA GCG GAG CAT GGT GG-39, where
the underlined CAT triplet represents the position of the ATG start
codon). Briefly, the mST75 primer was labeled with [g-32P]ATP (ICN
Biochemicals, Inc.) using the primer extension kit from Promega Corp.,
then denatured and allowed to anneal to 1 mg mouse placental or fetal
liver poly(A)1 RNA overnight at 60 C in the presence of 80% formamide,
40 mm PIPES (pH 6.4), 0.4 M NaCl, and 1 mm EDTA. After ethanol
precipitation, RT was carried out for 1 h using 40 U AMV reverse
transcriptase (Boehringer Mannheim, Indianapolis, IN). Reaction prod-
ucts were extracted with phenol, precipitated with ethanol, and run on
an 8% polyacrylamide 7 m urea gel. To allow an accurate determination
of product size, sequencing reactions were also performed using the
same primer and were loaded onto the same gel in adjacent lanes. The
sequencing reactions were performed using a 1.5-kb BamHI/KpnI frag-
ment of the D3 genomic clone (that had been subcloned into pBluescript)
as a template, [35S]deoxy-ATP (ICN Biochemicals, Inc.) as a labeling
reagent, and the Sequenase 2.0 kit from United States Biochemical Corp.
(Cleveland, OH).
Results
Isolation and sequence analysis of a Dio3 clone
We screened a mouse liver genomic library with a rat D3
cDNA probe and isolated a positive clone containing a 12-kb
DNA insert. Restriction analysis followed by Southern blot-
ting using the full length or various fragments of the rat D3
cDNA allowed us to deduce the structural features of Dio3,
as shown in Fig. 1. An example of this analysis is shown in
Fig. 2, where the genomic clone in the l Dash II vector has
been digested with KpnI and BamHI. A diagram of the lo-
cation of these restriction sites in the isolated clone is shown
in Fig. 2A. As shown in lane 1 of Fig. 2B, digestion results in
fragments of approximately 17.5, 10.5, and 1.5 kb derived
largely from the vector arms and five fragments of 4.2, 3.2,
2.0, 1.5, and 0.7 kb derived from the Dio3 gene insert. These
fragments were then subjected to Southern analysis, using as
probes the fragments of the rat D3 cDNA shown in Fig. 2A.
As shown in lane 2 of Fig. 2B, a portion of the rat D3 cDNA
corresponding to the 59-UT region plus 178 bp of the ad-
joining coding region (probe A) hybridized only to the 1.5 kb
restriction fragment. A similar result was observed using
probe B, which is derived entirely from the rat D3 coding
region (lane 3). Probe C encompassing the entire 39-UT re-
gion of the rat cDNA hybridized to both the 1.5- and 4.2-kb
fragments (lane 4).
These results suggested that the entire length of the D3
mRNA that is expressed in the placenta and skin was en-
coded within the segment of the Dio3 gene that encompassed
FIG. 1. Restriction map and structural
features of the 12-kb mouse Dio3
genomic fragment. The single exon is
shown with the open reading frame in-
dicated by the hatched area.
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the 1.5- and 4.2-kb restriction fragments. This was confirmed
by subcloning the 2.5-kb HindIII/SmaI restriction fragment
that contained the D3 cDNA sequences into pBluescript.
Sequencing of this fragment and comparing it to the rat
neonatal skin D3 cDNA sequence demonstrated that the
murine D3 gene contains a single exon, 1853 nucleotides in
length, that encodes the placenta/skin mRNA.
The predicted coding region sequence of the mouse Dio3
(Fig. 3) shows high homology to the rat (6) and human (7) D3
cDNAs at both the nucleotide (96% rat and 87% human
identity) and the predicted amino acid (99% rat and 96%
human identity) levels. This includes an in-frame TGA triplet
that codes for selenocysteine. A high degree of nucleotide
identity (94%) is also noted in the SECIS-containing portion
of the 39-UT region and in the overall 39-UT region (86%),
including the presence of a consensus polyadenylation se-
quence at the 39-end. As expected, lesser degrees of homol-
ogy are observed when comparing the mouse D3 protein to
those of lower species; amino acid identities with X. laevis (5)
and chicken (23) D3 are 55% and 58%, respectively.
Northern analysis of RNA extracted from mouse placenta
and probed with a 1.2-kb HindIII/BamHI genomic fragment
from the mouse coding region (see Fig. 1) demonstrated a D3
transcript similar in size (2.2 kb) to that previously described
in the rat (Fig. 4). As a positive control, RNA from epidermal
growth factor-stimulated rat brown preadipocytes was in-
cluded on this blot (14).
Defining the promoter region of the mouse D3 gene
A sequence comparison of the putative 59-UT regions of
the mouse, rat (6), and human D3 (7) cDNAs demonstrated
that the first 64 nucleotides 59 of the ATG translational start
site are identical. Thereafter, however, the sequences diverge
to some extent, suggesting that the transcriptional start site
could be in this region. To more precisely determine its
location, primer extension experiments were performed us-
ing mouse placenta and liver poly(A)1 as a template and a
labeled oligonucleotide primer whose 39-end was immedi-
ately upstream of the translational start site. Analysis of the
reaction products showed a predominant band approxi-
mately 75 bp in size and a lesser band of 92 bp, with placenta
and liver poly(A)1 RNA resulting in the same pattern of
bands (Fig. 5). Additional primer extension experiments us-
ing a variety of denaturing and annealing conditions were
performed, and in all cases both reaction products were
obtained, although their relative abundances varied. In most
reactions, the larger reaction product was more abundant. Of
note, this region of the genomic sequence is GC rich, which
could have accounted for these varying results. Given the
FIG. 2. A, A diagram of the KpnI and
BamHI restriction sites in the Dio3
genomic clone (including the l Dash II
vector). Lettered fragments correspond
to the bands in lane 1 of B. Shown in the
lower portion of this figure is a map
illustrating the positions of the rat D3
cDNA probes used for the Southern
analysis. B, Southern analysis of Dio3
KpnI/BamHI restriction fragments
probed with various portions of the rat
D3 cDNA. Lane 1, Ethidium bromide-
stained restriction fragments after aga-
rose gel electrophoresis. Fragments of
17 and 10.5 kb represent the phage vec-
tor arms plus, in the case of the smaller
band, terminal sequences from the
genomic insert. Bands of 4.2, 3.2, 2.0,
and 0.7 kb are derived from the genomic
insert. The 1.5-kb band represents two
fragments of the same size, one that
includes promoter and exonic se-
quences of the Dio3 genomic insert
(band d) and one from the vector arm
(band g). Lane 2, Southern blot of re-
striction fragments probed with a por-
tion of the rat D3 cDNA containing the
59-UT region and 178 bp of the coding
region (probe A). Lane 3, Southern blot
probed with a portion of the coding re-
gion of the rat D3 cDNA (probe B). Lane
4, Southern blot probed with the 39-UT
region of the rat D3 cDNA (probe C).
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location of the mST75 primer used in the primer extension
studies, the sizes of the reaction products indicates that the
transcriptional start sites are 77 and 60 nucleotides upstream
of the ATG translational start codon.
The two putative transcriptional start sites, as defined by
primer extension, are located 29 and 46 bp downstream of a
consensus TATA box (Fig. 3). Upstream of this element are
putative CAAT and GC box sequences on both strands of the
DNA, consistent with this being the promoter region of the
D3 gene. Notably, the sequence in this region is GC rich, a
feature that is common to many gene promoters. To deter-
mine whether this region could serve as a functional pro-
moter, a 526-bp KpnI/XhoI fragment, located immediately
upstream of the most 39-putative transcriptional start site
(see Fig. 3), was subcloned in front of a luciferase reporter
gene in the pXP2 vector. This construct was transfected into
COS-7 cells, Xenopus XTC-2 and XL-2 cells, and primary
preadipocytes derived from rat brown fat. Luciferase activity
FIG. 3. Nucleotide sequence of the
mouse Dio3 exon and approximately 500
nucleotides of the immediate upstream
region. The transcriptional start sites, as
determined by primer extension analy-
sis, are indicated by asterisks above the
boxed nucleotides at positions 506 and
523. The ATG translational start codon is
at position 583, and the TGA selenocys-
teine codon is at position 1012. Various
consensus promoter elements present on
either strand of the DNA are shown in
solid boxes, and restriction enzyme sites
are outlined in dotted boxes. The con-
served SECIS element extends from nu-
cleotides 1961–2010. The underlined nu-
cleotides at 578–597 represent the
location of the mST75 antisense oligonu-
cleotide used in the primer extension
reactions.
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was then determined in cell lysates. The pXP2 plasmid con-
taining only the luciferase gene was used as a negative con-
trol, and the plasmid pCH110 in which the b-galactosidase
gene is driven by the simian virus 40 early promoter was
used as a control for transfection efficiency. As shown in Fig.
6, luciferase activity was minimal in cells transfected with the
pXP2 control plasmid. However, in cells transfected with the
construct containing the KpnI/XhoI D3 genomic fragment,
luciferase activity was increased 500-5000 times, demonstrat-
ing the presence of strong promoter elements within this
region. Activity was highest in the preadipocyte and XL-2
cells, with considerably less activity observed in COS-7 cells.
To further characterize the key elements responsible for
the basal activity of the D3 promoter, we subcloned a 214-bp
SmaI/XhoI restriction fragment or the above-described
526-bp KpnI/XhoI fragment into the pGL3 luciferase reporter
vector (Promega Corp.). Both of these constructs included the
putative TATA box at their 39-ends. In addition, two similar
constructs that lacked the putative TATA box were prepared
by using the HindIII restriction site as the 39-end of the
fragment. These four constructs, in addition to the pGL3
vector containing luciferase alone as the negative control,
were transfected individually into XTC-2 cells along with the
b-galactosidase reporter plasmid, and luciferase activity was
then determined (Fig. 7). Both the 526- and 214-bp genomic
fragments, which contain the intact TATA element, demon-
strated strong promoter activity. In contrast, deletion from
both constructs of the TATA box largely eliminated promoter
activity.
Discussion
The D3 is unique among the selenodeiodinases in that it
catalyzes exclusively inner ring deiodination and is most
highly expressed in mammals during early fetal develop-
ment and in the placenta (1). This expression pattern in effect
isolates the fetal thyroid axis from that of the mother and
appears designed to maintain T4 and T3 levels relatively low
FIG. 6. Analysis of promoter function of a 526-bp KpnI/XhoI Dio3
fragment. The genomic fragment was cloned into the pXP2 vector so
as to drive luciferase activity, and this construct was then transfected
into COS-7, XTC-2, or XL-2 cells or into primary cultures of rat
preadipocytes derived from neonatal brown fat. Luciferase activity
was determined in cell lysates 48 h after transfection. Cells were also
cotransfected with a b-galactosidase expression plasmid for correc-
tion of transfection efficiency. The data in the first column, labeled no
promoter, are derived from transfection of the empty pXP2 vector into
COS-7 cells and are representative of the values obtained when this
vector was transfected into the other cell lines. The values shown are
the mean 6 SD of triplicate dishes from a single experiment. Similar
findings were noted in a replicate experiment.
FIG. 4. Northern analysis of total RNA (20 mg) from cultured rat
brown preadipocytes (lane rB) and mouse placenta [2 mg poly(A)1;
lane mP] probed with a portion of the coding region of the mouse D3
genomic clone.
FIG. 5. Primer extension reaction using mouse placental or fetal
mouse liver poly(A)1 RNA as template and the mST75 antisense
oligonucleotide shown in Fig. 3 as primer. Sequencing reactions pre-
pared with the same primer are shown for size comparison. The
location of the putative TATA box is indicated.
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in the early stages of development. To the extent that the level
of the D3 is regulated by transcriptional processes, its pro-
moter region must contain control elements that dictate its
expression in both a tissue-specific and developmental stage-
related manner. In addition, the D3 appears to be regulated
by a number of hormones (16–18) and growth factors (14, 15)
that probably influence its expression patterns during de-
velopment and in the adult. In the present report, we describe
the isolation and initial characterization of the mouse Dio3.
The availability of this genetic material should provide im-
portant insights into the developmental regulation of thyroid
hormone metabolism and action.
The major features of the mouse Dio3 gene are 1) that its
sequence in both the coding and 39-UT regions has been
highly conserved among diverse species; 2) that a single exon
encodes the full length of the mRNA species expressed in the
placenta and skin; and 3) that its promoter region, which is
located within 78 bp of the translational start site, is a C1G-
enriched (80%) region containing a TATA box that is critical
for its function as well as CAAT and GC boxes. Initial char-
acterization of a human P1 clone containing the DIO3 gene
indicates that these structural features have been conserved
in this species (Hernandez and St. Germain, unpublished
studies). In addition, sequence analysis demonstrates 80%
nucleotide identity between the first 500 bp of the mouse and
human promoter regions. This high degree of structural con-
servation may attest to the importance of the developmental
role of this enzyme throughout the vertebrate kingdom.
Our identification of the promoter region of the mouse
Dio3 gene is based on 1) the results of Northern analysis,
which identified the size of the mouse D3 mRNA to be
approximately 2.2 kb; 2) the results of primer extension ex-
periments, which place the start site(s) of transcription at 77
and/or 60 bp upstream of the translational initiation codon;
3) the structural features of the putative upstream regulatory
region, which contains several consensus basal promoter
elements; and 4) the ability of this region to drive high levels
of expression of a heterologous gene construct in a number
of cell culture systems. Thus, a 526-bp region upstream of the
start of transcription induces high levels of luciferase re-
porter activity in Xenopus XTC-2 and XL-2 cell lines and in
primary cultures of preadipocytes from rat brown fat. These
cells express endogenous D3 activity or can be induced to do
so by treatment with various hormones or growth factors. In
contrast, promoter activity, although present, is greatly at-
tenuated in COS-7 cells, which do not express D3 activity in
their native state. These results suggest that tissue-specific
regulatory elements may be present within the region of the
D3 promoter that was tested.
Although D3 expression is regulated by thyroid hormones
and retinoic acid in vivo (24, 25) and in cell culture systems
(16–18), no consensus sequences for thyroid hormone or
retinoic acid response elements are found by inspection of
the first 500 bp of the 59-flanking region. Growth factors and
phorbol esters have also been noted to stimulate D3 activity
and mRNA levels, but only limited information is available
on the transcription factors that mediate these transduction
pathways. Thus, further studies that will probably require
the characterization of additional upstream regulatory se-
quences will be needed to identify the elements involved in
conferring responsiveness to these factors.
This first report of the structure of a mammalian D3 gene
demonstrates that the coding region and known 59-UT and
39-UT regions, which include the SECIS element, are con-
tained within a single exon encompassing 1853 nucleotides.
Thus, D3 may be a member of a relatively small group of
single exon genes. Such genes comprise only 6% of the typical
mammalian genome, although they are more common in
lower species (26). Larger D3 transcripts have been observed
in the rat brain (6), however, suggesting that alternative
polyadenylation sites or additional exons may be present in
the Dio3 gene.
The D3 genomic structure defined herein contrasts with
the recently described structures of the human DIO1 (27) and
DIO2 (28), which contain four and two exons, respectively.
As it is reasonable to hypothesize that the three deiodinase
genes have evolved from a common ancestor, this variability
in genomic structure is of considerable interest. Further com-
parative studies of the genomic structures of this family of
genes in different species may provide important clues con-
cerning their evolutionary development.
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